GFAP and central nervous system cancer: Serum GFAP was significantly increased in Grade 4 glioma and was detected in 63% of all Grade 4 patients compared to 13% of healthy controls, [20] indicating that glioma patients had higher GFAP levels, in accordance with our findings.